Kiora Pharmaceuticals, Inc. (KPRX)
1.915
+0.02
(+1.32%)
USD |
NASDAQ |
Mar 31, 16:00
1.915
0.00 (0.00%)
After-Hours: 16:43
Kiora Pharmaceuticals EPS Diluted (Quarterly) : -1.732 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.223 |
| Plus Therapeutics, Inc. | -0.0412 |
| Atossa Therapeutics, Inc. | -1.270 |
| Abeona Therapeutics, Inc. | -0.3717 |
| Cell Source, Inc. | -0.021 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.516M |
| Total Expenses (Quarterly) | 6.516M |
| Enterprise Value | -9.770M |
| Earnings Yield | -145.5% |
| Normalized Earnings Yield | -110.77 |